tumor
-
Trends
Immunai wants to map the entire immune system and raised $20 million in seed funding to do it
For the past two years the founding team of Immunai had been working stealthily to develop a new technology to…
Read More » -
Trends
NEA-backed Personal Genome Diagnostics receives FDA clearance for its cancer diagnostic
Personal Genome Diagnostics, the venture-backed developer of a novel diagnostic kit for genomic profiling of different cancers in lab settings,…
Read More »